Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 91,010 shares at $74.79 ($7.0M) on 2016-12-15, disclosed to the SEC on 2017-01-04.
Open-market sale of $7.0M EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.79 | 3,730 | $279K | 4.0% |
| 2 | $74.79 | 6,270 | $469K | 6.7% |
| 3 | $74.79 | 3,730 | $279K | 4.0% |
| 4 | $74.79 | 6,270 | $469K | 6.7% |
| 5 | $75.61 | 2,683 | $203K | 2.9% |
| 6 | $75.61 | 7,317 |
| $553K |
| 8.0% |
| 7 | $75.61 | 7,317 | $553K | 8.0% |
| 8 | $75.61 | 2,683 | $203K | 2.9% |
| 9 | $76.69 | 10,000 | $767K | 11.0% |
| 10 | $77.17 | 2,683 | $207K | 3.0% |
| 11 | $77.17 | 7,569 | $584K | 8.4% |
| 12 | $77.17 | 2,683 | $207K | 3.0% |
| 13 | $77.17 | 7,569 | $584K | 8.4% |
| 14 | $76.78 | 5,126 | $394K | 5.7% |
| 15 | $76.78 | 5,126 | $394K | 5.7% |
| 16 | $78.61 | 5,127 | $403K | 5.8% |
| 17 | $78.61 | 5,127 | $403K | 5.8% |
| Total | $76.37 avg | 91,010 | $7.0M | 100% |
| Filing → |
| EGRX | SELL | 2016-12-02 | $479K | — | Filing → |
| EGRX | SELL | 2015-06-18 | $814K | — | Filing → |